A recent study from Liu et al. [75] used whole-exome sequencing and RNA sequencing data from BRCA1-deficient mouse mammary tumours to identify multiple aberrations capable of activating the MAPK and/or PI3K signalling pathways. This evidence concerns the gene BRCA1 and breast cancer.